Ecron Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Vecuronium Br

Indications/Uses

Adjuvant to anesth to facilitate endotracheal intubation & to provide skeletal muscle relaxation during surgery.

Dosage/Direction for Use

Intubation & subsequent surgical procedures Initially 80-100 mcg/kg IV. Incremental doses: 30-50 mcg/kg IV.

Contraindications

Previous anaphylactic reactions to vecuronium Br.

Special Precautions

Neuromuscular disease, severe obesity; after poliomyelitis. Electrolyte imbalances, dehydration, acidosis. Renal insufficiency & liver disorder, myasthenia gravis.

Adverse Reactions

Anaphylactic reactions.

View ADR Reporting Link

Drug Interactions

Increased effects w/ anesth, nondepolarizing muscle relaxants, prior administration of suxamethonium, aminoglycoside & polypeptide antibiotics, diuretics, β-blockers, thiamine, MAOIs, quinidine, protamine, imidazole, metronidazole, α-blockers. Decreased effects w/ neostigmine, theophylline.

MIMS Class

Neuromuscular Blocking Agents

ATC Classification

M03AC03 - vecuronium ; Belongs to the class of other quaternary ammonium-containing agents used as peripherally-acting muscle relaxants.

Regulatory Classification

Presentation/Packing

Form

Ecron inj 10 mg

Packing/Price

(vial) 1's (Rp210,000/vial)

Form

Ecron inj 4 mg

Packing/Price

1 mL x 10 × 1's (Rp935,000/boks)

Ecron

vecuronium bromide

Manufacturer:

Korea United Pharm

Marketer:

Pharos